Dr. Cherie S. Tan is an Associate Professor of Medical College at the Tianjin University. She was raised in Harbin, China, and California, US. Her undergraduate training was in analytical chemistry with Prof. Janusz Pawliszyn, a Fellow of the Royal Society of Canada, at the University of Waterloo.  After obtaining her Bachelor’s Degree in Canada, she moved back to California and spent four years working in the San Francisco Bay Area biotechnology industry. During that time, she developed her skills to become a senior Bioanalytical Scientist of DMPK department (Drug Metabolism Pharmacokinetics) at Novartis Institutes for BioMedical Research, the World's top 3 pharmaceutical company. In order to further understand the expression of cancer-related genes and developed an analytical method for fast screening of the targeted genes, she pursued her Ph.D. degree in a Nanopore Sequencing of DNA Damage group, operated by Professor Cynthia J.Burrows, a fellow of the National Academy of Sciences, and Professor Henry White, a fellow of the American Academy of Arts and Sciences. Following a postdoctoral appointment at the same group, she began her academic career as an associate professor at Tianjin University in 2019.